Bayer warns US lawmakers it may halt Roundup sales without stronger legal protections: report
Portfolio Pulse from
Bayer AG has warned US lawmakers it may stop selling its Roundup weedkiller in the US unless stronger legal protections are provided to shield the company from product liability lawsuits. Bayer has already paid $10 billion to settle claims related to Roundup's alleged cancer risks.
March 07, 2025 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bayer AG is considering halting US sales of Roundup unless it receives stronger legal protections against liability lawsuits. This follows $10 billion in settlements over cancer claims.
The potential halt in Roundup sales could impact Bayer's revenue from the US market. The ongoing legal challenges and significant settlement costs highlight the financial and reputational risks Bayer faces, likely leading to negative short-term stock price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90